Analysis of ANC recovery from a Phase III study of lipegfilgrastim versus pegfilgrastim in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

被引：0
|
作者：
Bondarenko, I. [1 ]
Bias, P. [2 ]
Elsaesser, R. [2 ]
Buchner, A. [2 ]
机构：
[1] Dnepropetrovsk Municipal Clin Hosp 4, Dnepropetrovsk, Ukraine
[2] Teva Ratiopharm, Ulm, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1961
引用
收藏
页码：S434 / S435
页数：2
相关论文
共 50 条
  • [31] A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
    Byeong Seok Sohn
    Jae Ho Jeong
    Jin-Hee Ahn
    Kyung Hae Jung
    Jeong Eun Kim
    Joo Hyuk Sohn
    Su-Jin Koh
    Jae Hong Seo
    Keun Seok Lee
    Sung-Bae Kim
    Investigational New Drugs, 2020, 38 : 866 - 873
  • [32] A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy
    Sohn, Byeong Seok
    Jeong, Jae Ho
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Jeong Eun
    Sohn, Joo Hyuk
    Koh, Su-Jin
    Seo, Jae Hong
    Lee, Keun Seok
    Kim, Sung-Bae
    INVESTIGATIONAL NEW DRUGS, 2020, 38 (03) : 866 - 873
  • [33] Efficacy and safety of pegfilgrastim biosimilar MD-110 in patients with breast cancer receiving chemotherapy: Single-arm phase III
    Takano, Toshimi
    Ito, Mitsuya
    Kadoya, Takayuki
    Osako, Tomofumi
    Aruga, Tomoyuki
    Masuda, Norikazu
    Miyaki, Toshiko
    Niikura, Naoki
    Shimizu, Daisuke
    Yokoyama, Yuichi
    Watanabe, Manabu
    Tomomitsu, Masato
    Aogi, Kenjiro
    CANCER MEDICINE, 2023, 12 (20): : 20242 - 20250
  • [34] Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer
    Ganem, G
    Tubiana-Hulin, M
    Fumoleau, P
    Combe, M
    Misset, JL
    Vannetzel, JM
    Bachelot, T
    De Ybarlucea, LR
    Lotz, V
    Bendahmane, B
    Dieras, V
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1623 - 1628
  • [35] Neutrophil recovery in elderly breast cancer patients receiving adjuvant anthracycline-containing chemotherapy with pegfilgrastim support
    Brugger, W.
    Bacon, P.
    Lawrinson, S.
    Romieu, G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 (03) : 265 - 269
  • [36] Ciprofloxacin, G-CSF, Pegfilgrastim, Pegfilgrastim plus Ciprofloxacin as neutrophil support during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients
    von Minckwitz, G.
    Blohmer, J.
    Loehr, A.
    Raab, G.
    Eidtmann, H.
    Gerber, B.
    Hilfrich, J.
    Huober, J.
    Costa, S.
    Kaufmann, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 98 - 98
  • [37] Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial
    Masuda, Norikazu
    Tokuda, Yutaka
    Nakamura, Seigo
    Shimazaki, Ryutaro
    Ito, Yoshinori
    Tamura, Kazuo
    SUPPORTIVE CARE IN CANCER, 2015, 23 (10) : 2891 - 2898
  • [38] Neoadjuvant biweekly chemotherapy with liposomal doxorubicin and docetaxel in patients with stage II-III breast cancer
    Alvarez, I
    Modolell, A.
    Mayordomo, J., I
    Heras, L.
    Villadiego, K.
    Rolfo, C. D.
    Garcia-Bueno, J. M.
    Pica, P.
    Murillo, L.
    Morales, S.
    Valera, P.
    Florian, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S229 - S229
  • [39] Empiric dose reduction of pegfilgrastim in breast cancer patients receiving cytotoxic chemotherapy
    Paba, C.
    Sachdev, J.
    Kronish, L.
    Jahanzeb, M.
    Waheed, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [40] A Phase III Randomized Equivalence Study of Biosimilar Filgrastim versus Amgen Filgrastim in Patients Receiving Myelosuppressive Chemotherapy for Breast Cancer
    Waller, Cornelius F.
    Semiglazov, Vladimir F.
    Tjulandin, Sergei
    Bentsion, Dmitry
    Chan, Stephen
    Challand, Rodeina
    ONKOLOGIE, 2010, 33 (10): : 504 - 511
12345